Real-world experience with CPX-351 in high-risk acute myeloid leukemia
2023 · Critical Reviews in Oncology/Hematology · 17 citations
https://doi.org/10.1016/j.critrevonc.2023.103984
A
Akriti Jain
Cleveland Clinic(US)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
206
Papers
759
Citations
14
h-index
20
i10-index
Akriti Jain is an academic researcher from Cleveland Clinic. The author has contributed to research in topics: Acute Myeloid Leukemia Research & Chronic Myeloid Leukemia Treatments & Myeloproliferative Neoplasms: Diagnosis and Treatment. The author has an h-index of 14, co-authored 176 publications.
ORCID: 0000-0002-7238-9241Papers by this author
worksCandida parapsilosis: An Unusual Cause of Infective Endocarditis
2018 · Cureus · 16 citations
https://doi.org/10.7759/cureus.3553
Incidence of pleural effusion with dasatinib and the effect of switching therapy to a different TKI in patients with chronic phase CML
2024 · Annals of Hematology · 12 citations
https://doi.org/10.1007/s00277-024-05760-6
Severe Rhabdomyolysis as an Unusual Presentation of Primary Human Immunodeficiency Virus Infection
2018 · Cureus · 7 citations
https://doi.org/10.7759/cureus.3041
Pseudohyperkalemia: To Treat or not to Treat
2018 · Cureus · 7 citations
https://doi.org/10.7759/cureus.3570
Drug-induced Thrombotic Microangiopathy Caused by Gemcitabine
2018 · Cureus · 5 citations
https://doi.org/10.7759/cureus.3088
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat